Cargando…

Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis

BACKGROUND: Cannabis use following the onset of first-episode psychosis has been linked to both increased risk of relapse and non-adherence with antipsychotic medication. Whether poor outcome associated with cannabis use is mediated through an adverse effect of cannabis on medication adherence is un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoeler, Tabea, Petros, Natalia, Di Forti, Marta, Klamerus, Ewa, Foglia, Enrico, Murray, Robin, Bhattacharyya, Sagnik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522816/ https://www.ncbi.nlm.nih.gov/pubmed/28705600 http://dx.doi.org/10.1016/S2215-0366(17)30233-X

Ejemplares similares

The effect of cannabis use on memory function: an update
por: Schoeler, Tabea, et al.
Publicado: (2013)

Can cognitive insight predict symptom remission in a first episode psychosis cohort?
por: O’Connor, Jennifer A., et al.
Publicado: (2017)

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
por: Colizzi, Marco, et al.
Publicado: (2020)

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
por: Patel, Rashmi, et al.
Publicado: (2016)

F102. CHANGE IN PATTERNS OF CANNABIS AND OTHER SUBSTANCE USE OVER TIME IN EARLY PSYCHOSIS- EXAMINING THE EFFECT OF DEVELOPMENT OF PSYCHOSIS
por: Sami, Musa, et al.
Publicado: (2018)

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
por: González-Pinto, Ana, et al.
Publicado: (2011)

Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis
por: González-Ortega, Itxaso, et al.
Publicado: (2015)

Cannabis use during first episode psychosis in Tunisia
por: Bergaoui, E., et al.
Publicado: (2023)

Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
por: Schoeler, Tabea, et al.
Publicado: (2022)

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
por: Mondelli, Valeria, et al.
Publicado: (2015)

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
por: Hindocha, Chandni, et al.
Publicado: (2020)

Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior
por: Colizzi, Marco, et al.
Publicado: (2020)

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
por: Sami, Musa Basseer, et al.
Publicado: (2018)

Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis
por: Sami, Musa, et al.
Publicado: (2020)

Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2018)

17. CANNABIDIOL AS A TREATMENT IN DIFFERENT STAGES OF PSYCHOSIS- EFFICACY AND MECHANISMS
por: Bhattacharyya, Sagnik
Publicado: (2018)

Cannabinoids, reward processing, and psychosis
por: Gunasekera, Brandon, et al.
Publicado: (2021)

Eye movements in patients in early psychosis with and without a history of cannabis use
por: Sami, Musa Basseer, et al.
Publicado: (2021)

T26. PERINATAL STRESS AND PSYCHOSIS: RESULTS FROM THE BOLOGNA FIRST EPISODE PSYCHOSIS (BO-FEP) STUDY
por: Tarricone, Ilaria, et al.
Publicado: (2018)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

Cannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape
por: Sami, Musa, et al.
Publicado: (2020)

Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study
por: Barbeito, Sara, et al.
Publicado: (2013)

Medication adherence in first-episode psychosis and its association with psychopathology
por: Raghavan, Vijaya, et al.
Publicado: (2019)

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
por: Quattrone, Diego, et al.
Publicado: (2021)

Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use
por: Mhalla, Ahmed, et al.
Publicado: (2017)

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
por: Colizzi, Marco, et al.
Publicado: (2017)

T238. RATES AND PREDICTORS OF RELAPSE IN AN AUSTRALIAN FIRST EPISODE PSYCHOSIS COHORT
por: Brown, Ellie, et al.
Publicado: (2020)

The right occipital lobe and poor insight in first-episode psychosis
por: Tordesillas-Gutierrez, Diana, et al.
Publicado: (2018)

Cannabis and psychosis: Neurobiology
por: Shrivastava, Amresh, et al.
Publicado: (2014)

Cannabis Induced Psychosis
por: Bramness, J.
Publicado: (2022)

The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia
por: Leeson, Verity C., et al.
Publicado: (2012)

F100. FACTOR STRUCTURE OF THE CANNABIS EXPERIENCES QUESTIONNAIRE IN A FIRST-EPISODE PSYCHOSIS SAMPLE
por: Birnbaum, Michael, et al.
Publicado: (2018)

Cannabis use in first episode psychosis: what we have tried and why it hasn’t worked
por: McDonell, Michael G., et al.
Publicado: (2019)

A Comparison of Cognitive Performance in Patients With Parkinson's Disease Psychosis According to Psychosis Severity: A Meta-Analysis
por: Gosse, Luca, et al.
Publicado: (2023)

Serum and gene expression profile of cytokines in first-episode psychosis
por: Di Nicola, Marco, et al.
Publicado: (2013)

S126. THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE
por: Quattrone, Diego, et al.
Publicado: (2020)

Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis
por: Penzel, Nora, et al.
Publicado: (2022)

S101. CLINICAL FACTORS ASSOCIATED WITH CANNABIS USE IN A CHILEAN SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS
por: Iruretagoyena, Barbara, et al.
Publicado: (2018)

T97. CANNABIS USE IMPACTS SYMPTOM PRESENTATION IN ANTIPSYCHOTIC NAIVE PATIENTS IN FIRST EPISODE OF PSYCHOSIS (FEP)
por: Coutinho, Luccas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fneti5h750rgsofde6anve5n6a